Viewing Study NCT02609659


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2025-12-29 @ 10:45 PM
Study NCT ID: NCT02609659
Status: COMPLETED
Last Update Posted: 2019-12-10
First Post: 2015-11-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C Virus (HCV) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Hepatitis C Infection View